Differences in clinical outcomes between pre- and post-marketing clinical study following paclitaxel-coated balloon catheter treatment for coronary in-stent restenosis: from the Japanese regulatory viewpoint.

MLA

Mitsutake, Yoshiaki, et al. “Differences in Clinical Outcomes between Pre- and Post-Marketing Clinical Study Following Paclitaxel-Coated Balloon Catheter Treatment for Coronary in-Stent Restenosis: From the Japanese Regulatory Viewpoint.” Heart and Vessels, vol. 36, no. 2, Feb. 2021, pp. 155–62. EBSCOhost, https://doi.org/10.1007/s00380-020-01676-z.

APA

Mitsutake, Y., Konishi, A., Shiba, T., Ito, T., Ho, M., & Shirato, H. (2021). Differences in clinical outcomes between pre- and post-marketing clinical study following paclitaxel-coated balloon catheter treatment for coronary in-stent restenosis: from the Japanese regulatory viewpoint. Heart and Vessels, 36(2), 155–162. https://doi.org/10.1007/s00380-020-01676-z

Chicago

Mitsutake, Yoshiaki, Akihide Konishi, Takeshi Shiba, Takuya Ito, Mami Ho, and Haruki Shirato. 2021. “Differences in Clinical Outcomes between Pre- and Post-Marketing Clinical Study Following Paclitaxel-Coated Balloon Catheter Treatment for Coronary in-Stent Restenosis: From the Japanese Regulatory Viewpoint.” Heart and Vessels 36 (2): 155–62. doi:10.1007/s00380-020-01676-z.